INDUCTION OF MAMMARY-GLAND TUMOURS IN RATS AND MICE
BY HORMONES AND CHEMICAL CARCINOGENS J. HOOSON Fromt BIBRA, Carshalton, Surrey CANCER OF THE BREAST is the most commonly occurring neoplasm in women, and consequently has been the subject of intensive study. Mammary cancer also occurs spontaneously in rats and mice, and these species have been the most frequently used in laboratory investigations. By now, it is well known that neoplasia in the mammary gland can be influenced by a variety of factors. Genetic, hormonal, viral, immunological, dietary and other environmental factors are involved in varying degrees in determining spontaneous mammary cancer in rodents (Nandi & McGrath, 1973) .
Chemical induction of mammary neoplasia has been studied experimentally in rodents after treatment with hormones and chemical carcinogens.
Induction of mammary cancer by hormones
A high incidence of mammary cancers has been induced in rats and mice by administration of natural and synthetic steroidal and non-steroidal oestrogens, and anterior-pituitary hormones. Frequency of tumour induction varies with strain, but in all cases the hormone must be given continuously over a long period of time at levels much above the physiological replacement dose. Depending on dose, latent periods can vary from 100 to 700 days (Jull, 1976; Lacassagne, 1937) .
Pituitary adenomas accompany the appearance of mammary cancer, and such observations have led to the hypothesis that oestrogens are oncogenic because of their stimulatory effect on prolactin secretion (Firth, 1973 was followed by degenerative changes and cyst formation; focal dysplastic changes were seen in areas of epithelium lining the cysts, which progressed to malignancy. In some animals, malignant change was limited to discrete areas within one gland; in others all mammary glands were neoplastic. Pituitary adenomas were found in all treated rats, and immunohistochemical staining revealed an increase in prolactin-secreting cells. Atrophy of uterine and ovarian tissues also occurred. Hypophysectomy or treatment with bromocriptine, a specific inhibitor of prolactin secretion, abolished the neoplastic response, but oophorectomy had no effect on tumour induction. Similar changes have been found in mammary tissue of rodents administered natural oestrogens (Geschicter, 1945 (Armstrong & Bonser, 1947; Bonser & Orr, 1939; Young & Hallowes, 1973) . N-methyl-N-nitrosourea (MNU) (5 mg/ 100 g) administered to rats, produced 100% incidence of mammary carcinomas, the first tumours arising by 7 weeks. Sequential analysis of mammary tissue before tumour development did not reveal any hyperplastic changes. Tumours arose abruptly from ductular structures in the unstimulated gland. Pituitary histology was normal, as were other endocrine glands. However, hypophysectomy or oophorectomy before MNU administration abolished the neoplastic response.
Similar results have been reported with DMBA and 3-methylcholanthrene (Young & Hallowes, 1973) . The presence of certain hormones appears to be a sine qua non in the induction of cancer by carcinogenic chemicals.
In the Berenblum hypothesis of 2-stage carcinogenesis, hormones apparently participate at both stages. Physiological levels of hormones are necessary for initiation to occur. Pathological levels of hormones can act as promoters on transformed epithelium. Under certain conditions it is also believed that they can act as anti-promoters (Welch & Nagasawa, 1977) .
Comment
From the above account it is clear that different mechanisms of carcinogenicity exist in the rodent mammary gland. The production of mammary tumours by chemicals in routine toxicity tests must be examined critically in the light of such knowledge. It is important to distinguish between carcinogenesis mediated by a direct effect of the test chemical on mammary epithelium, and carcinogenesis elicited by an indirect action on known modulators of mammary neoplasia. Indirect action via hormonal pathways has been described, but other pathways may also be involved. For a final assessment of the carcinogenic potential ofchemicals in humans, an appreciation of such mechanisms is essential.
MALIGNANT LYMPHOMAS IN RODENTS
N. TEICH From the Imperial Cancer Research Fund, Lincoln's Inn Fields, London ONCOGENIC VIRUSES have been identified in several mammalian species such as mouse, rat, cat, dog and primates, and there is indirect evidence that they may also be present in man for a limited number of tumours, e.g. Burkitt's lymphoma, Hodgkin's disease and nasopharyngeal carcinoma.
Mice harbour a variety of oncogenic viruses, particularly the so-called lymphoma viruses. They form part of the genetic make-up of the mouse, and appear to be activated unpredictably by a number of factors. This may account for the variable incidence of lymphomas in successive generations of mice.
